Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesHomeMammography acquisition parameters affect both AI, radiologist readsThe findings could help clinicians better develop "effective strategies for the clinical integration of AI," researchers noted.HomeWhat prompts radiology department cancellations of imaging orders?Digital X-RayAI model detects achalasia on chest x-raysCTImaging linked to blood cancers in children and adolescentsUltrasoundEchogenic rind on breast ultrasound holds diagnostic significance